Below are the five companies in the Drug Manufacturers industry with the highest year-over-year expected earnings per share (EPS) growth rates.
Amphastar Pharmaceuticals Inc. ranks highest with EPS growth of 638.6%. Following is Gilead Sciences Inc. with EPS growth of 334.5%. China SXT Pharmaceuticals Inc. ranks third highest with EPS growth of 242.6%.
Eagle Pharmaceuticals Inc. follows with EPS growth of 189.4%, and Pfizer Inc. rounds out the top five with EPS growth of 97.0%.
InvestorBrandNetwork is monitoring the Drugs-Generic Industry for any potential shift so investors can protect gains.
Receive IBN`s Technical Indicator Alerts
To stay connected with our complimentary IBN alerts, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. IBN has a proven track record and has served 500+ client partners. IBN is the key to more effective market communication.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer